International Society For Vaccines Makes Its Debut, Planning To Address Needs Of A Maturing Discipline

Planning To Address Needs Of A Maturing Discipline Author: NEERAJA SANKARAN, pp.1 Date: July 11,1994 The formation of a new scientific organization, the Gaithersburg, Md.-based International Society for Vaccines (ISV), signals that vaccinology is finally coming of age as a discrete discipline, according to Jonas Salk, the developer of the first effective vaccine for polio--whose own experience in the field spans more than a half-c

Written byNeeraja Sankaran
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Planning To Address Needs Of A Maturing Discipline Author: NEERAJA SANKARAN, pp.1
Date: July 11,1994

The formation of a new scientific organization, the Gaithersburg, Md.-based International Society for Vaccines (ISV), signals that vaccinology is finally coming of age as a discrete discipline, according to Jonas Salk, the developer of the first effective vaccine for polio--whose own experience in the field spans more than a half-century.

Although vaccines have been in use, in some form, for almost 200 years, formation of the new society, say its members, marks the first time that researchers with that focus have come together as a single, international organization to share their common interests. Until recently, they say, the subject was always addressed in the context of a researcher's specific field, and this included virtually every area of the basic and applied biological sciences-- immunology, virology, molecular biology, parasitology, pediatrics, and the veterinary sciences being a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies